Clinical trial
A Study of Short-Term Outcomes and Economic Impact For Patients With Worsening…
NCT00270387 · Scios, Inc., Industry · Completed
Key facts
| NCT number | NCT00270387 |
|---|---|
| Title | A Study of Short-Term Outcomes and Economic Impact For Patients With Worsening Congestive Heart Failure When Natrecor (Nesiritide) is Added to Standard-Care Therapy, Compared to Administration of Placebo With Standard-Care Therapy |
| Official title | Prospective Randomized Outcomes Study of Acutely Decompensated Congestive Heart Failure Treated Initially in Outpatients With Natrecor (Nesiritide) - The PROACTION Trial |
| Lead sponsor | Scios, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cardiomyopathies, Heart Failure, Congestive, Dyspnea, Paroxysma |
| Intervention type | Drug |
| Interventions | Natrecor (nesiritide) |
| Enrollment | 250 |
| Start date | Jan 1, 2001 |
| Completion | Jan 1, 2002 |
| First posted | Dec 26, 2005 |
| Last update posted | Dec 13, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: